Adicet Bio, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Adicet Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Adicet Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $6M, a 19.5% increase year-over-year.
  • Adicet Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $22.2M, a 21.5% increase year-over-year.
  • Adicet Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $20.3M, a 18.3% increase from 2022.
  • Adicet Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $17.1M, a 36.9% increase from 2021.
  • Adicet Bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12.5M, a 138% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $20.3M +$3.13M +18.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $17.1M +$4.62M +36.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $12.5M +$7.25M +138% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $5.26M +$4.09M +348% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $1.18M -$1.3M -52.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $2.48M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.